-
1
-
-
0021153959
-
Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines
-
Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 1984;230:232-236.
-
(1984)
J Pharmacol Exp Ther
, vol.230
, pp. 232-236
-
-
Bousquet, P.1
Feldman, J.2
Schwartz, J.3
-
2
-
-
0033933265
-
Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization
-
Piletz JE, Ivanov TR, Sharp JD, et al. Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. DNA Cell Biol 2000;19:319-329.
-
(2000)
DNA Cell Biol
, vol.19
, pp. 319-329
-
-
Piletz, J.E.1
Ivanov, T.R.2
Sharp, J.D.3
-
3
-
-
0034638831
-
Nischarin, a novel protein that interacts with the integrin alpha5 subunit and inhibits cell migration
-
Alahari SK, Lee JW, Juliano RL. Nischarin, a novel protein that interacts with the integrin alpha5 subunit and inhibits cell migration. J Cell Biol 2000;151:1141-1154.
-
(2000)
J Cell Biol
, vol.151
, pp. 1141-1154
-
-
Alahari, S.K.1
Lee, J.W.2
Juliano, R.L.3
-
4
-
-
33646381125
-
Imidazoline receptors, novel agents and therapeutic potential
-
Head GA, Mayorov DN. Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem 2006;4:17-32.
-
(2006)
Cardiovasc Hematol Agents Med Chem
, vol.4
, pp. 17-32
-
-
Head, G.A.1
Mayorov, D.N.2
-
5
-
-
41149121472
-
Growth retardation versus overgrowth: Silver-Russell syndrome is genetically opposite to Beckwith-Wiedemann syndrome
-
Eggermann T, Eggermann K, Schonherr N. Growth retardation versus overgrowth: Silver-Russell syndrome is genetically opposite to Beckwith-Wiedemann syndrome. Trends Genet 2008;24:195-204.
-
(2008)
Trends Genet
, vol.24
, pp. 195-204
-
-
Eggermann, T.1
Eggermann, K.2
Schonherr, N.3
-
6
-
-
0037205482
-
Insulin receptor substrate 4 associates with the protein IRAS
-
Sano H, Liu SC, Lane WS, Piletz JE, Lienhard GE. Insulin receptor substrate 4 associates with the protein IRAS. J Biol Chem 2002;277:19439-19447.
-
(2002)
J Biol Chem
, vol.277
, pp. 19439-19447
-
-
Sano, H.1
Liu, S.C.2
Lane, W.S.3
Piletz, J.E.4
Lienhard, G.E.5
-
7
-
-
0028269271
-
Agmatine: an endogenous clonidine-displacing substance in the brain
-
Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994;263:966-969.
-
(1994)
Science
, vol.263
, pp. 966-969
-
-
Li, G.1
Regunathan, S.2
Barrow, C.J.3
Eshraghi, J.4
Cooper, R.5
Reis, D.J.6
-
8
-
-
84857644129
-
Imidazoline receptor antisera-selected/Nischarin regulates the effect of agmatine on the development of morphine dependence
-
Li F, Wu N, Su R, et al. Imidazoline receptor antisera-selected/Nischarin regulates the effect of agmatine on the development of morphine dependence. Addict Biol 2012;17:392-408.
-
(2012)
Addict Biol
, vol.17
, pp. 392-408
-
-
Li, F.1
Wu, N.2
Su, R.3
-
9
-
-
0038729643
-
A biphasic opioid function modulator: agmatine
-
Su RB, Li J, Qin BY. A biphasic opioid function modulator: agmatine. Acta Pharmacol Sin 2003;24:631-636.
-
(2003)
Acta Pharmacol Sin
, vol.24
, pp. 631-636
-
-
Su, R.B.1
Li, J.2
Qin, B.Y.3
-
10
-
-
46149109259
-
Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence
-
Wu N, Su RB, Li J. Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence. Cell Mol Neurobiol 2008;28:629-641.
-
(2008)
Cell Mol Neurobiol
, vol.28
, pp. 629-641
-
-
Wu, N.1
Su, R.B.2
Li, J.3
|